Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nippon Chemiphar To Re-examine Partnership With Ranbaxy

This article was originally published in PharmAsia News

Executive Summary

At a July 29 press briefing in Tokyo, Nippon Chemiphar President Kazushiro Yamaguchi questioned a partnership with India's biggest drug maker Ranbaxy Laboratories. Yamaguchi stated that since 2002 when the two companies signed an agreement to expand the generic drugs market through joint venture Nihon Pharmaceutical Industry, no finished products have been launched, which had been planned in the partnership. Yamaguchi also indicated a possibility of looking for a new partner since it is hard to compete in the market alone. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069188

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel